Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy JanOne stock
Learn how to easily invest in JanOne stock.
JanOne Inc is a waste management business based in the US. JanOne shares (JAN) are listed on the NASDAQ and all prices are listed in US Dollars. JanOne employs 172 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in JanOne
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – JAN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
JanOne stock price (NASDAQ: JAN)Use our graph to track the performance of JAN stocks over time.
JanOne shares at a glance
|Latest market close||$2.98|
|52-week range||$2.65 - $31.83|
|50-day moving average||$4.37|
|200-day moving average||$6.35|
|Wall St. target price||$4.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.49|
Buy JanOne shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy JanOne stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
JanOne price performance over time
|1 week (2022-01-19)||-5.40%|
|1 month (2021-12-23)||-32.27%|
|3 months (2021-10-26)||-50.33%|
|6 months (2021-07-26)||-57.25%|
|1 year (2021-01-26)||-53.80%|
|2 years (2020-01-24)||-9.42%|
|3 years (2019-01-25)||484.31%|
|5 years (2017-01-26)||159.13%|
|Revenue TTM||$38.5 million|
|Gross profit TTM||$8.8 million|
|Return on assets TTM||-19.31%|
|Return on equity TTM||-210.25%|
|Market capitalisation||$8.4 million|
TTM: trailing 12 months
JanOne share dividends
We're not expecting JanOne to pay a dividend over the next 12 months.
Have JanOne's shares ever split?
JanOne's shares were split on a 1:5 basis on 21 April 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your JanOne shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for JanOne shares which in turn could have impacted JanOne's share price.
JanOne share price volatility
Over the last 12 months, JanOne's shares have ranged in value from as little as $2.65 up to $31.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while JanOne's is 1.4156. This would suggest that JanOne's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
JanOne Inc. , a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain. It operates in three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc.
JanOne in the news
Price Capital Management, Inc. Buys JanOne Inc, Sells iShares U.S. ...
Earnings playbook: A complete guide to this week's reports, including the first of tech
ATP Life Science Ventures, L.P. Buys JanOne Inc
Frequently asked questionsWhat percentage of JanOne is owned by insiders or institutions?
Currently 17.717% of JanOne shares are held by insiders and 16.045% by institutions. How many people work for JanOne?
Latest data suggests 172 work at JanOne. When does the fiscal year end for JanOne?
JanOne's fiscal year ends in December. Where is JanOne based?
JanOne's address is: 325 East Warm Springs Road, Las Vegas, NV, United States, 89119 What is JanOne's ISIN number?
JanOne's international securities identification number is: US47089W1045 What is JanOne's CUSIP number?
JanOne's Committee on Uniform Securities Identification Procedures number is: 03814F106
More guides on Finder
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert